Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Bioconjug Chem ; 26(4): 773-81, 2015 Apr 15.
Article in English | MEDLINE | ID: mdl-25811535

ABSTRACT

The synthesis of water-soluble dyes, which absorb and emit in the range between 650 and 950 nm and display high extinction coefficients (ε) as well as high fluorescence quantum yields (Φf), is still a demand for optical imaging. We now present a synthetic route for the preparation of a new group of glycerol-substituted cyanine dyes from dendronized indole precursors that have been functionalized as N-hydroxysuccinimide (NHS) esters. High Φf values of up to 0.15 and extinction coefficients of up to 189 000 L mol(-1) cm(-1) were obtained for the pure dyes. Furthermore, conjugates of the new dendronized dyes with the antibody cetuximab (ctx) that were directed against the epidermal growth factor receptor (EGFR) of tumor cells could be prepared with dye to protein ratios between 0.3 and 2.2 to assess their potential as imaging probes. For the first time, ctx conjugates could be achieved without showing a decrease in Φf and with an increasing labeling degree that exceeded the value of the pure dye even at a labeling degree above 2. The incorporation of hydrophilically and sterically demanding dendrimers into cyanines prevented dimer formation after covalent conjugation to the antibody. The binding functionality of the resulting ctx conjugates to the EGFR was successfully demonstrated by cell microscopy studies using EGFR expressing cell lines. In summary, the combination of hydrophilic glycerol dendrons with reactive dye labels has been established for the first time and is a promising approach toward more powerful fluorescent labels with less dimerization.


Subject(s)
Carbocyanines/chemistry , Contrast Media/chemical synthesis , Dendrimers/chemistry , Fluorescent Dyes/chemical synthesis , Glycerol/chemistry , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Cell Line, Tumor , Cetuximab/chemistry , Cetuximab/pharmacology , Contrast Media/chemistry , Epithelial Cells/drug effects , Epithelial Cells/metabolism , Epithelial Cells/pathology , ErbB Receptors/antagonists & inhibitors , ErbB Receptors/genetics , ErbB Receptors/metabolism , Fluorescent Dyes/chemistry , Gene Expression , Humans , Hydrophobic and Hydrophilic Interactions , Immunoconjugates/chemistry , Immunoconjugates/pharmacology , Indoles/chemistry , Microscopy, Fluorescence , Optical Imaging , Staining and Labeling/methods
2.
J Med Chem ; 63(21): 12614-12622, 2020 11 12.
Article in English | MEDLINE | ID: mdl-32931274

ABSTRACT

The synthesis, characterization, biological activity, and toxicology of sila-ibuprofen, a silicon derivative of the most common nonsteroidal anti-inflammatory drug, is reported. The key improvements compared with ibuprofen are a four times higher solubility in physiological media and a lower melting enthalpy, which are attributed to the carbon-silicon switch. The improved solubility is of interest for postsurgical intravenous administration. A potential for pain relief is rationalized via inhibition experiments of cyclooxygenases I and II (COX-I and COX-II) as well as via a set of newly developed methods that combine molecular dynamics, quantum chemistry, and quantum crystallography. The binding affinity of sila-ibuprofen to COX-I and COX-II is quantified in terms of London dispersion and electrostatic interactions in the active receptor site. This study not only shows the potential of sila-ibuprofen for medicinal application but also improves our understanding of the mechanism of action of the inhibition process.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/metabolism , Ibuprofen/chemistry , Silicon/chemistry , Anti-Inflammatory Agents, Non-Steroidal/chemical synthesis , Anti-Inflammatory Agents, Non-Steroidal/chemistry , Binding Sites , Carbon/chemistry , Catalytic Domain , Cyclooxygenase 1/chemistry , Cyclooxygenase 1/metabolism , Cyclooxygenase 2/chemistry , Cyclooxygenase 2/metabolism , Humans , Ibuprofen/metabolism , Molecular Conformation , Molecular Dynamics Simulation , Protein Binding , Quantum Theory , Static Electricity
3.
J Control Release ; 194: 189-96, 2014 Nov 28.
Article in English | MEDLINE | ID: mdl-25176577

ABSTRACT

Herein we present a FRET-based theranostic macromolecular prodrug (TMP) composed of (a) dendritic polyglycerol (PG) as polymeric nanocarrier, (b) doxorubicin (Dox) linked via a pH-sensitive hydrazone to (c) a tri-functional linker, and (d) an indodicarbocyanine dye (IDCC) attached in close proximity to Dox. The drug fluorescence is quenched via intramolecular FRET until the pH-sensitive hydrazone bond between the TMP and Dox is cleaved at acidic pH. By measuring its fluorescence, we characterized the TMP cleavage kinetics at different pH values in vitro. The intracellular release of Dox from the carrier was monitored in real time in intact cancer cells, giving more insight into the mode of action of a polymer drug conjugate.


Subject(s)
Antibiotics, Antineoplastic/administration & dosage , Antibiotics, Antineoplastic/chemistry , Doxorubicin/administration & dosage , Doxorubicin/chemistry , Fluorescence Resonance Energy Transfer/methods , Prodrugs/administration & dosage , Prodrugs/chemistry , Diagnostic Imaging , Drug Carriers/chemistry , Fluorescent Dyes , Glycerol/chemistry , HeLa Cells , Humans , Hydrazones/chemistry , Hydrogen-Ion Concentration , Kinetics , Nanoparticles , Polymers/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL